DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS
Mark Identification

DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS

Serial Number

85525585

Filing Date

Jan 26, 2012

Trademark by

ASTRAZENECA AB

Classification Information

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use for pharmaceutical research and development

Computer and Scientific